COMMUNIQUÉS West-GlobeNewswire

Latin America: The Next Cannabis Frontier -- CFN Media

02/11/2018 - 14:00

SEATTLE, Nov. 02, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing [...]

Medibio Market Update

02/11/2018 - 14:00

SYDNEY, Australia and MINNEAPOLIS, Minn., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company ) (ASX: MEB)(OTCQB: MDBIF), a mental health technology company, today shares a market update to the recent [...]

Teligent, Inc. to Present at Jefferies London Healthcare Conference on Wednesday November 14, 2018

02/11/2018 - 13:45

BUENA, N.J., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at Jefferies London Healthcare Conference. The Conference is [...]

Results of Cynata’s World-First GvHD Clinical Trial Accepted for Presentation at American Society of Hematology Annual Meeting

02/11/2018 - 13:45

MELBOURNE, Australia, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: CYP), a clinical-stage biotechnology company specializing in cell therapeutics, is pleased to announce that results from Cohort A [...]

Terra Tech Corp. to Report Third Quarter 2018 Earnings on Thursday, November 8, 2018

02/11/2018 - 13:30

IRVINE, Calif., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp. (OTCQX: TRTC) (“Terra Tech” or the “Company”), a vertically integrated, cannabis-focused agriculture company, today announced that it will release its [...]

Sarepta Therapeutics to Present at Credit Suisse 27th Annual Healthcare Conference

02/11/2018 - 13:30

CAMBRIDGE, Mass., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a leader in precision genetic medicine for rare diseases, today announced that management will present at the Credit Suisse [...]

Obalon Announces Third Quarter 2018 Financial Results

02/11/2018 - 13:01

SAN DIEGO, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon [...]

Achaogen to Host Conference Call and Webcast of Third Quarter 2018 Financial Results on November 8, 2018

02/11/2018 - 13:01

SOUTH SAN FRANCISCO, Calif., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug [...]

Humanigen Announces Lenzilumab Study Results Accepted as Oral Presentation at the 2018 Annual Meeting of the American Society of Hematology (ASH)

02/11/2018 - 13:00

Study Demonstrates that GM-CSF Neutralization with Lenzilumab in Combination with Chimeric Antigen Receptor T (CAR-T) Cell Therapy Prevents the Onset of Cytokine Release Syndrome, Significantly Reduces the Severity of [...]

ORYZON Reports Financial Results and Corporate Update for the 3rd Quarter Ended September 30, 2018

02/11/2018 - 13:00

-$0.01/share for the 9 months ended September 30th MADRID, Spain and CAMBRIDGE, Mass., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Oryzon Genomics (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company [...]

Checkpoint Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights

02/11/2018 - 13:00

NEW YORK, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]

Abiomed to Present at the Stephens 2018 Investment Conference in New York, NY

02/11/2018 - 13:00

DANVERS, Mass., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief [...]

Caelum Biosciences Announces Data on CAEL-101 in AL Amyloidosis Selected for Oral Presentations at 60th American Society of Hematology Annual Meeting

02/11/2018 - 13:00

NEW YORK, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Caelum Biosciences, Inc. (“Caelum”), a company focused on developing treatments for rare and life-threatening diseases, today announced that additional global longitudinal [...]

Pernix Therapeutics to Report Third Quarter 2018 Financial Results on Thursday, November 8

02/11/2018 - 13:00

MORRISTOWN, N.J., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, announced today that the Company will report financial results for the third [...]

Caladrius Biosciences to Host Third Quarter 2018 Financial Results Conference Call on Thursday, November 8, 2018 at 4:30 p.m. ET

02/11/2018 - 13:00

BASKING RIDGE, N.J., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company with multiple technology platforms targeting [...]

Catalyst Biosciences Announces Presentation at the 60th American Society of Hematology Annual Meeting & Exposition

02/11/2018 - 13:00

SOUTH SAN FRANCISCO, Calif., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]

Intensity Therapeutics Raises $6.5 Million in Series B Financing

02/11/2018 - 12:35

Proceeds to enable advancement of lead product candidate INT230-6 into Phase 2 clinical development for solid tumors WESTPORT, Conn., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Intensity Therapeutics, Inc. , a clinical-stage [...]

Neos Therapeutics to Host Third Quarter 2018 Financial Results Conference Call on November 9, 2018

02/11/2018 - 12:30

DALLAS and FORT WORTH, Texas, , Nov. 02, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ: NEOS) today announced that it will report third quarter 2018 financial results prior to the opening of U.S. financial [...]

Stemline Therapeutics Announces Four ELZONRIS Presentations, Including an Oral Presentation, at Upcoming ASH Meeting

02/11/2018 - 12:30

NEW YORK, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, announced today that [...]